Mentions
Extended reach
Total likes
Video views
AI synopsis
Numerous discussions highlighted the findings about cross-reactive T cells and their role in enhancing immune response, such as a post mentioning that even a lower dose could prompt a strong immune response comparable to natural infection. Phrases like 'important finding' and 'good news' used by participants illustrate an optimistic tone that underscores the perceived relevance and potential benefits of the research.
The majority of discussions show general support for the findings of the study, indicating a moderate to strong agreement among participants about the results.
The discussions reflect a high level of interest, with several participants engaging in the topic and sharing insights, indicating relevance to ongoing conversations about vaccines.
While the engagement is moderate, many posts delve into the implications of the study and shared personal insights related to T cell responses, showing some level of depth.
Many contributors express the belief that the results of the publication could have significant implications for understanding vaccine effectiveness, which suggests a notable perceived impact.
A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger and older patients, and which could be enhanced by the presence of cross-reactive T cells, researchers report in Science. https://t.co/ZtvZR0bHpi https://t.co/A2sw3AYND7
A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger and older patients, and which could be enhanced by the presence of cross-reactive T cells, researchers report in Science. https://t.co/ZtvZR0bHpi https://t.co/wTsQrcZM8T
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The latest study from our group @Dani6020, @profshanecrotty shows durable memory antibody and T cell responses following RNA vaccination
Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad de vacunas. Acá, un 1/5 de la dosis habitual de la de Moderna funcionó prácticamente igual que la infección natural a 7 meses. https://t.co/lEoisaqeNj https://t.co/wnJyaT6nVt
Amid the reports you're likely to see that some antibodies to prior SARS-CoV-2 variants don't bind well to Omicron (you probably will, because they probably won't) it will help to remember that even low-dose vaccination elicits robust memory T-cell defense https://t.co/om9zsXK8f1
1/4量のmRNAでもワクチン効果は十分だったという論文。 半年後でも感染者からの回復者と同等の液性、細胞性免疫が維持されていた。 Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/DnX2s3d9SV
This video examines the effectiveness of COVID-19 vaccines in reducing transmission of the Delta variant among household members. Vaccinated individuals demonstrated significant effectiveness, highlighting vaccines'…
Vaccinated individuals clear SARS-CoV-2 faster than unvaccinated ones. This video discusses the effectiveness of vaccines against the Delta variant, emphasizing that while one dose shows lower efficacy, two doses…
@DaiyamondoNoTe @ArminPh @sonas893 @kleinleise @Annette_A_P @glasspateldruck @CorneliaBeeking @KinderdocNina @DrCWerner @dregenus @DocGlitz @paediatrice1 Da ist das letzte Worte noch nicht gesprochen. Lesen Sie mal diese Studien: https://t.co/uWocMuySPy https://t.co/KPtH972UEu https://t.co/yf1nL1Rpbz https://t.co/4aF5xGJ5jx https://t.co/tDguWZwBKe https://t.co/L3LhEHaemh https://t.co/61md2I8vml
@Neil3McCormick @ClaudeSteve6 @Mimimolette5 or, par exemple dans cette étude, quand on regarde on voit bien qu'on les a les ig. et même les lymphocytes mémoire. https://t.co/u5PwsQ9CNz https://t.co/g5JDOqS57D
@Afinetheorem @bechhof @ATabarrok ? Where's that from? Immunological research actually finds the durability & protection from vaccines is comparable to or slightly greater than from natural infections. (https://t.co/5Awnfv9DiQ & https://t.co/MMjpqa728i)
RT @profshanecrotty: Overall, lots of good news about T cell memory to RNA vaccines! https://t.co/vDMSnT3OBo
@55stitches @robblue477 This is a jargon-y paper about lower vs higher doses of the vaccine. It essentially says the vaccine makes the body produce anti-spike-protein antibodies, without doing the damage of introducing spikes to it in the first place. https://t.co/FNlYRgRu1y
@jmacho162 @Ouyevolitub @SabrinaRWilhelm @risahoshinoMD https://t.co/V5Axs65ZjX
@moggonomics101 @Jillymo527 @joncoopertweets You understood me perfectly well, and if you didn't, you'd have looked more intelligent just letting it slide. Chief. Next. You can ask me for two if you like. I know how you enjoy reading these in your spare moments https://t.co/E7qHb827pz
@Gerli0815 @Claus_Pandi Wie bitte? Sie halten mich für einen Bot? sorry, da liegen Sie komplett falsch.. nur ein kleiner Auszug vom Stand der Wissenschaft https://t.co/s6Wqkn9rpr
@vrilbit @kurtseifried @dragonfly_jenny @RachelNotley Here’s another study showing that the approved vaccines prompt your immune system to produce protective T cells: https://t.co/xBt2hHPAzk
@laurenweinstein Science links in article: https://t.co/GK5yr27cwZ https://t.co/3FrBOZv0wM
@kazuchancocone 要旨だけでなく、論文のデータを吟味されました？インターフェロンの反応の変化、むっちゃ微妙じゃないですか。インフルにもちゃんと反応できてますし。一方、T細胞は長期間保持されることが示されています。https://t.co/zsO7Q7tdOZ 参考までにこちらもつけておきます。 https://t.co/BkGeHsZgwy
@pbleic Thanks for your answer. :) How serious can we take this in light of this paper? https://t.co/xK5bgJHsKa
@700sachen Zu geringe Dosis glaube ich eher nicht. Diese Paper zeigt, auch eine niedrigere Dosis kommt mit recht gutem Schutz. https://t.co/xK5bgJHsKa
@SebiwanC A l'époque de l'écriture de la revue narrative, j'avais trouvé ça : https://t.co/LIFY45mHSH https://t.co/yWWfLIEYnn https://t.co/vPGL7UobsZ
@KittyMiau16 https://t.co/RHXXgQWyWc https://t.co/nVxBKXkcMf https://t.co/6KJD0GIXmE 8 Monate waren Ausnahmefälle, bisher keine Regel.
Mateus J, Dan JM, Zhang Z, Rydyznski Moderbacher C, Lammers M, Goodwin B, Sette A, Crotty S, Weiskopf D. Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells. Science. 2021 Oct 22;374(6566):eabj9853.
RT @hussmanjp: Amid the reports you're likely to see that some antibodies to prior SARS-CoV-2 variants don't bind well to Omicron (you prob…
RT @hussmanjp: Amid the reports you're likely to see that some antibodies to prior SARS-CoV-2 variants don't bind well to Omicron (you prob…
RT @hussmanjp: Amid the reports you're likely to see that some antibodies to prior SARS-CoV-2 variants don't bind well to Omicron (you prob…
RT @hussmanjp: Amid the reports you're likely to see that some antibodies to prior SARS-CoV-2 variants don't bind well to Omicron (you prob…
RT @hussmanjp: Amid the reports you're likely to see that some antibodies to prior SARS-CoV-2 variants don't bind well to Omicron (you prob…
Amid the reports you're likely to see that some antibodies to prior SARS-CoV-2 variants don't bind well to Omicron (you probably will, because they probably won't) it will help to remember that even low-dose vaccination elicits robust memory T-cell defense https://t.co/om9zsXK8f1
Moderna COVID-19 vaccine spurs lasting immune response: new study https://t.co/5PjS8jUx6D https://t.co/Ht9PozSps5 https://t.co/u8ZjKNUBnO
@MonicaGandhi9 Seems new data suggests Moderna induces CD8 too : https://t.co/T14dtcpuUd If not, would a Pfizer boost help ?
@af_Kastning @altdoktorn @AlexanderWennlo @AYtterstrom 1. Det du citerade stödjer inte något du sagt 2. Covid-19 vaccinen i Europa är inaktiverat vitus 3. Det du citerade handlar om först c19 SEN vaccin. Utan vaccindelen så är t-cellsvaret efter infektion i genomsnitt som en låg dos vaccin, sämre än fulldos https://t.co/GPKqbq3cuE https://t.co/DBKoY7HOxo
@RadCentrism https://t.co/NTaiUjKRpj
@denise_dewald @NickytaLeb This is my point... https://t.co/bPmV78BaaE Beyond that, I like the design of this study that shows immune response persists beyond 6 months, even at 1/4 dose. It would have been nice if they'd have post dosed at 1/4 to measure endemic responses. https://t.co/0z62dB3syB
RT @rishirajgoel: Recommending boosters also does NOT mean that immunity is gone by 6 months... Data from @EJohnWherry @profshanecrotty @Th…
Recommending boosters also does NOT mean that immunity is gone by 6 months... Data from @EJohnWherry @profshanecrotty @TheBcellArtist shows 2 doses of mRNA generate strong immune memory to SARS-CoV-2: https://t.co/YHHBMrMsTA https://t.co/ukpWr4ek3S https://t.co/gTvh0Ek7Ak
@J_EmpyreanGoals @MriPhoneCanada @KindrachukJason @KStateTurk @ScienceUpFirst The immune response of a 25 mcg series of mRNA-1273 were comparable to those of SARS-CoV-2 infections, and 100 mcg was better. Throw in some prime-and-pull or heck maybe even just dose 3 and I think it's doable. https://t.co/DF4tBIa0YM https://t.co/F7BYEDmbZe
@BamaCrazy1 @RoscherMarcus @jeffm1981 @profshanecrotty Not just a guess, immune memory cells in lymph nodes are known to last a long time. https://t.co/X9rEA4O70P https://t.co/4YVP4mbe0w
@FaviaFrancesco @TipoNomeForma @fabius10scudi @Ussignur_ @enzo2308 @aspettaaspetta @Theskeptical_ @borghi_claudio @Docfelix81 @SabrySocial @Andunedhel @todorov_denis @Rosalba_Falzone @Federic49759244 @FerGionny @bertignac3 @BalliFrancesco @boni_castellane @MagisterZatta Qui alcuni esempi: https://t.co/Yvgie819GH https://t.co/IhBjCelrc8 https://t.co/bRuKTVYHGb
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/QWNYWs5V1M
RT @MichaelCebulla: @GVDBossche Maybe the CD4/8 response of vaccinated people gives at least a bit of a possible answer. https://t.co/6I6hk…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
#vaccine #covid #pandemic #getvaccinated Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/OBhnFytwiv
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger and older patients, and which could be enhanced by the presence of cross-reactive T cells, researchers report in Science. https://t.co/ZtvZR0bHpi https://t.co/A2sw3AYND7
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/RbAkixptB3
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/msKLluoGuq
https://t.co/wJCBu4Z8J7
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @BagaiDr: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/QSaSTErY2E
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
RT @ScienceMagazine: A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger an…
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/QSaSTErY2E
A low dose of the Moderna #COVID19 vaccine generated long-lived T cell immunity that was equivalent between younger and older patients, and which could be enhanced by the presence of cross-reactive T cells, researchers report in Science. https://t.co/ZtvZR0bHpi https://t.co/wTsQrcZM8T
https://t.co/mcEsXOvZYN モデルナのワクチン，1/4の容量で打っても通常の感染程度には抗体もメモリーT細胞も維持される。でもfull doseの方が強いとのこと。cross-reactive T cellもワクチンの効果を維持できると。
RT @maurodriguez: Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad…
RT @maurodriguez: Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad…
RT @maurodriguez: Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad…
@omarsery1 https://t.co/6MSs4GcJLN
RT @Derive_ip: なんか既視感がある論文なのですが、簡単に言うとモデルナのワクチンは４分の１でも十分に機能するというはなし。ちなみに、現在議論されている追加接種では２分の１になる予定なのですが、それでも多いということになりますかね。 https://t.co/Nti…
La vacuna de dosis baja mRNA-1273 COVID-19 (Moderna) [25 μg vs 100 μg] genera una memoria duradera mejorada por las células T de reacción cruzada. Una dosis más pequeña de la vacuna hace el trabajo. https://t.co/OnCAdI086P
RT @maurodriguez: Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad…
RT @maurodriguez: Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad…
RT @maurodriguez: Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad…
RT @maurodriguez: Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad…
RT @maurodriguez: Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad…
RT @maurodriguez: Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad…
RT @maurodriguez: Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad…
RT @maurodriguez: Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad…
Más evidencia: dosis fraccionadas de vacunas COVID-19 sí funcionan. Sería un incremento espectácular de la disponibilidad de vacunas. Acá, un 1/5 de la dosis habitual de la de Moderna funcionó prácticamente igual que la infección natural a 7 meses. https://t.co/lEoisaqeNj https://t.co/wnJyaT6nVt
RT @jmateust: Our study is officially out in https://t.co/yuhmYWAyTU. We (@Dani6020, @profshanecrotty, @SetteLab) have fascinating and enco…
RT @Derive_ip: なんか既視感がある論文なのですが、簡単に言うとモデルナのワクチンは４分の１でも十分に機能するというはなし。ちなみに、現在議論されている追加接種では２分の１になる予定なのですが、それでも多いということになりますかね。 https://t.co/Nti…
RT @Derive_ip: なんか既視感がある論文なのですが、簡単に言うとモデルナのワクチンは４分の１でも十分に機能するというはなし。ちなみに、現在議論されている追加接種では２分の１になる予定なのですが、それでも多いということになりますかね。 https://t.co/Nti…
Más sobre vacunas: https://t.co/E8OMkHgTfX
That sounds like great news. https://t.co/keRmDVmFbI
RT @Derive_ip: なんか既視感がある論文なのですが、簡単に言うとモデルナのワクチンは４分の１でも十分に機能するというはなし。ちなみに、現在議論されている追加接種では２分の１になる予定なのですが、それでも多いということになりますかね。 https://t.co/Nti…
RT @Derive_ip: なんか既視感がある論文なのですが、簡単に言うとモデルナのワクチンは４分の１でも十分に機能するというはなし。ちなみに、現在議論されている追加接種では２分の１になる予定なのですが、それでも多いということになりますかね。 https://t.co/Nti…
RT @Derive_ip: なんか既視感がある論文なのですが、簡単に言うとモデルナのワクチンは４分の１でも十分に機能するというはなし。ちなみに、現在議論されている追加接種では２分の１になる予定なのですが、それでも多いということになりますかね。 https://t.co/Nti…
—by Erin Bryant References: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells. https://t.co/fTAyAV2bib
RT @magmugbio: 1/4量のmRNAでもワクチン効果は十分だったという論文。 半年後でも感染者からの回復者と同等の液性、細胞性免疫が維持されていた。 Low-dose mRNA-1273 COVID-19 vaccine generates durable mem…
RT @magmugbio: 1/4量のmRNAでもワクチン効果は十分だったという論文。 半年後でも感染者からの回復者と同等の液性、細胞性免疫が維持されていた。 Low-dose mRNA-1273 COVID-19 vaccine generates durable mem…
RT @magmugbio: 1/4量のmRNAでもワクチン効果は十分だったという論文。 半年後でも感染者からの回復者と同等の液性、細胞性免疫が維持されていた。 Low-dose mRNA-1273 COVID-19 vaccine generates durable mem…
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells #COVID19 #COVIDVaccine #Tcells #immunity #Moderna #getvaccinated https://t.co/CkSZLvoAd3
Los estudios! Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/F8sdVQOuj6
RT @magmugbio: 1/4量のmRNAでもワクチン効果は十分だったという論文。 半年後でも感染者からの回復者と同等の液性、細胞性免疫が維持されていた。 Low-dose mRNA-1273 COVID-19 vaccine generates durable mem…
RT @magmugbio: 1/4量のmRNAでもワクチン効果は十分だったという論文。 半年後でも感染者からの回復者と同等の液性、細胞性免疫が維持されていた。 Low-dose mRNA-1273 COVID-19 vaccine generates durable mem…
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/9xvYYQb3Qd
1/4量のmRNAでもワクチン効果は十分だったという論文。 半年後でも感染者からの回復者と同等の液性、細胞性免疫が維持されていた。 Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/DnX2s3d9SV
Important finding for #CovidVaccine ! Pre-existing cross-reactive T cells acquired prior to the pandemic show beneficial impact on vaccination outcome. https://t.co/KWDCQozCx1 worth exploring in context of #CovidVaccines for kids #drvgsomani #NITIAayog #DBTIndia
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/sJUIyWYyZe #Covid_19 #COVID19
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/dxiIUYJ0Db
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/gEdPq8Ip0B
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/jmdYW7nQpI
Interesting!
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/PjCe6ygObK
RT @Dr_Khan: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/1rqXdgw3j7
RT @Dr_Khan: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/1rqXdgw3j7
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/1rqXdgw3j7
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/TQ8wQDMVk7
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/4gXr97D3y2 Cross-reactive T-cells: how many different MHC+peptide combinations does a single T-cell see? Don Mason?
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/F9eXVW8U04
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/zXErRSmjpo
RT @miltonlarrondo: Good News! Veamos que dice FDA mañana respecto a dosis de refuerzo. Low-dose mRNA-1273 COVID-19 vaccine generates dura…
Good News! Veamos que dice FDA mañana respecto a dosis de refuerzo. Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/r3csLoDcyT
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/0o9lGvbdY7
This new study, like other T cell study, also found no pre-existing CD8 T cells in the circulation (they are lymph nodes only), unlike CD4 T cells. Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/FiOkO0Ecjl
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/OTRDtmureX
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @AngelRoblesMarh: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/eSgWlW2YSh
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/eSgWlW2YSh
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/eevZ5rWp9m
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/dxiIUYJ0Db
CoronaCentral's top trending articles today are: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells. https://t.co/vHm593Fhee
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/9pzeL59XpW
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/M2YDGROuOd
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/kIJ0Zx77at https://t.co/yVWtqm2EcI
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/hnjh0bM5KL
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
RT @SetteLab: Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The l…
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/xOWbYnrU7d The latest study from our group @Dani6020, @profshanecrotty shows durable memory antibody and T cell responses following RNA vaccination
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/QSaSTErY2E
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/vDGz0hBvVG
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/VaYOhsmJWL
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/QSaSTEanb6
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/MGwdxWgVqM
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells https://t.co/Gj4q1m0MOG